481 related articles for article (PubMed ID: 11723060)
1. Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected].
Storgaard H; Song XM; Jensen CB; Madsbad S; Björnholm M; Vaag A; Zierath JR
Diabetes; 2001 Dec; 50(12):2770-8. PubMed ID: 11723060
[TBL] [Abstract][Full Text] [Related]
2. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA
J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626
[TBL] [Abstract][Full Text] [Related]
3. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
Beeson M; Sajan MP; Dizon M; Grebenev D; Gomez-Daspet J; Miura A; Kanoh Y; Powe J; Bandyopadhyay G; Standaert ML; Farese RV
Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907
[TBL] [Abstract][Full Text] [Related]
4. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.
Kim YB; Zhu JS; Zierath JR; Shen HQ; Baron AD; Kahn BB
Diabetes; 1999 Feb; 48(2):310-20. PubMed ID: 10334307
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.
Miyazaki Y; He H; Mandarino LJ; DeFronzo RA
Diabetes; 2003 Aug; 52(8):1943-50. PubMed ID: 12882909
[TBL] [Abstract][Full Text] [Related]
6. Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats.
Song XM; Kawano Y; Krook A; Ryder JW; Efendic S; Roth RA; Wallberg-Henriksson H; Zierath JR
Diabetes; 1999 Mar; 48(3):664-70. PubMed ID: 10078575
[TBL] [Abstract][Full Text] [Related]
7. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion.
Jessen N; Djurhuus CB; Jørgensen JO; Jensen LS; Møller N; Lund S; Schmitz O
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E194-9. PubMed ID: 15339744
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3' kinase activation, and impaired atypical protein kinase C (zeta/lambda) activation in myotubes from obese patients with impaired glucose tolerance.
Vollenweider P; Ménard B; Nicod P
Diabetes; 2002 Apr; 51(4):1052-9. PubMed ID: 11916925
[TBL] [Abstract][Full Text] [Related]
9. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients.
Krook A; Björnholm M; Galuska D; Jiang XJ; Fahlman R; Myers MG; Wallberg-Henriksson H; Zierath JR
Diabetes; 2000 Feb; 49(2):284-92. PubMed ID: 10868945
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation.
Pratipanawatr W; Pratipanawatr T; Cusi K; Berria R; Adams JM; Jenkinson CP; Maezono K; DeFronzo RA; Mandarino LJ
Diabetes; 2001 Nov; 50(11):2572-8. PubMed ID: 11679436
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats.
Ogihara T; Asano T; Ando K; Chiba Y; Sekine N; Sakoda H; Anai M; Onishi Y; Fujishiro M; Ono H; Shojima N; Inukai K; Fukushima Y; Kikuchi M; Fujita T
Diabetes; 2001 Mar; 50(3):573-83. PubMed ID: 11246877
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation.
Kruszynska YT; Worrall DS; Ofrecio J; Frias JP; Macaraeg G; Olefsky JM
J Clin Endocrinol Metab; 2002 Jan; 87(1):226-34. PubMed ID: 11788651
[TBL] [Abstract][Full Text] [Related]
13. Muscle damage impairs insulin stimulation of IRS-1, PI 3-kinase, and Akt-kinase in human skeletal muscle.
Del Aguila LF; Krishnan RK; Ulbrecht JS; Farrell PA; Correll PH; Lang CH; Zierath JR; Kirwan JP
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E206-12. PubMed ID: 10893341
[TBL] [Abstract][Full Text] [Related]
14. Insulin signaling in human skeletal muscle: time course and effect of exercise.
Wojtaszewski JF; Hansen BF; Kiens B; Richter EA
Diabetes; 1997 Nov; 46(11):1775-81. PubMed ID: 9356025
[TBL] [Abstract][Full Text] [Related]
15. Regulation of IRS-1/SHP2 interaction and AKT phosphorylation in animal models of insulin resistance.
Lima MH; Ueno M; Thirone AC; Rocha EM; Carvalho CR; Saad MJ
Endocrine; 2002 Jun; 18(1):1-12. PubMed ID: 12166618
[TBL] [Abstract][Full Text] [Related]
16. Regulation of IRS-2 tyrosine phosphorylation in fasting and diabetes.
Rojas FA; Hirata AE; Saad MJ
Mol Cell Endocrinol; 2001 Oct; 183(1-2):63-9. PubMed ID: 11604226
[TBL] [Abstract][Full Text] [Related]
17. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
18. Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart.
Laviola L; Belsanti G; Davalli AM; Napoli R; Perrini S; Weir GC; Giorgino R; Giorgino F
Diabetes; 2001 Dec; 50(12):2709-20. PubMed ID: 11723053
[TBL] [Abstract][Full Text] [Related]
19. Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes.
Meyer MM; Levin K; Grimmsmann T; Perwitz N; Eirich A; Beck-Nielsen H; Klein HH
Diabetes; 2002 Sep; 51(9):2691-7. PubMed ID: 12196460
[TBL] [Abstract][Full Text] [Related]
20. Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2005 Aug; 54(8):2351-9. PubMed ID: 16046301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
